Meribank Biotech Co (ROCO:4724) FCF Margin %: 14.84% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4724 Meribank Biotech Co Ltd ROCO:4724
40 GF Score
Price NT$9.78
GF Value NT$48.90
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Meribank Biotech Co FCF Margin %?

Meribank Biotech Co ROCO:4724 -3.65% 40 FCF Margin % is 14.84% as of Dec. 2025. GuruFocus rates ROCO:4724 with a GF Score™ of 40/100 and a GF Value™ of NT$48.90 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 950 Biotechnology companies, Meribank Biotech Co ranks better than 88.21% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Meribank Biotech Co's Free Cash Flow for the six months ended in Dec. 2025 was NT$32.8 Mil. Meribank Biotech Co's Revenue for the six months ended in Dec. 2025 was NT$221.3 Mil. Therefore, Meribank Biotech Co's FCF Margin % for the quarter that ended in Dec. 2025 was 14.84%.

As of today, Meribank Biotech Co's current FCF Yield % is 9.01%.

The historical rank and industry rank for Meribank Biotech Co's FCF Margin % or its related term are showing as below:

ROCO:4724' s FCF Margin % Range Over the Past 10 Years
Min: -104.32   Med: -14.26   Max: 17.93
Current: 17.93

During the past 8 years, the highest FCF Margin % of Meribank Biotech Co was 17.93%. The lowest was -104.32%. And the median was -14.26%.

ROCO:4724's FCF Margin % is ranked better than
88.21% of 950 companies
in the Biotechnology industry
Industry Median: -81.28 vs ROCO:4724: 17.93

Meribank Biotech Co FCF Margin % Related Terms

Meribank Biotech Co FCF Margin % Historical Data

* Premium members only.

The historical data trend for Meribank Biotech Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Meribank Biotech Co FCF Margin % Chart

Meribank Biotech Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial -18.71 -25.30 -15.52 -104.32 17.93

Meribank Biotech Co Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.44 -280.40 -7.13 20.65 14.84

ROCO:4724 vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Meribank Biotech Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Meribank Biotech Co FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Meribank Biotech Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Meribank Biotech Co's FCF Margin % falls into.


ROCO:4724
40GF Score
Meribank Biotech Co Ltd ROCO:4724
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Meribank Biotech Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Meribank Biotech Co's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=84.566/471.763
=17.93 %

Meribank Biotech Co's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=32.843/221.347
=14.84 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 14.84% mean?
Meribank Biotech Co (ROCO:4724) has a FCF Margin % of 14.84% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Meribank Biotech Co and its competitors. According to the industry distribution chart, Meribank Biotech Co ranks #112 out of 950 companies in the Biotechnology industry, placing it in the top 11.8%.
Is Meribank Biotech Co's FCF Margin % too high?
Meribank Biotech Co's current FCF Margin % is 14.84%. Based on the distribution chart, Meribank Biotech Co ranks #112 out of 950 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Meribank Biotech Co has a GF Score™ of 40/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Meribank Biotech Co's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Meribank Biotech Co ranks #112 out of 950 companies for FCF Margin %. This places Meribank Biotech Co in the top 12% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Meribank Biotech Co and its competitors. Meribank Biotech Co's current FCF Margin % is 14.84%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Meribank Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Meribank Biotech Co (ROCO:4724) is currently considered Possible Value Trap. The stock's GF Value™ is NT$48.90, compared to a current price of NT$9.78 — trading 80% below its estimated fair value. The current FCF Margin % is 14.84%. Meribank Biotech Co's overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Meribank Biotech Co (ROCO:4724), the current FCF Margin % is 14.84% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Meribank Biotech Co (ROCO:4724) Overvalued in 2026?

Based on GuruFocus' analysis, Meribank Biotech Co stock appears to be undervalued. The current stock price of NT$9.78 is trading 80% below its estimated GF Value™ of NT$48.90. GuruFocus considers Meribank Biotech Co to be Possible Value Trap.

Key valuation signals for ROCO:4724:

  • FCF Margin %: 14.84%
  • GF Value™: NT$48.90 vs. price of NT$9.78 (80% below fair value)
  • GF Score™: 40/100 with 6 warning signs

No single metric tells the full story. See the ROCO:4724 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Meribank Biotech Co Business Description

Address Sector 1, Neihu Road, 1st Floor, No.68, Neihu District, Taipei, TWN, 11493
Meribank Biotech Co Ltd is engaged in Research and development and sales of new cell drugs and also Umbilical cord blood, placenta and umbilical cord mesenchymal stem cells processing, testing and cryopreservation.
40GF Score

Get the complete analysis for ROCO:4724

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$9.78
Price
NT$48.90
GF Value